The primary uses of<unk>  are to treat dyslipidemia and to prevent atherosclerosis-related complications such as stroke and heart attacks in those who are at high risk. It is recommended to be used as an addition to a low-cholesterol diet. In heart protection studies,<unk>  showed the ability to lower LDL cholesterol by about 1·5 mmol/L, which resulted in substantial reductions in mortality rates.<unk>  also reduced the numbers of other events like heart attacks, strokes, and revascularizations and MI significantly. The Heart Protection Study evaluated the effects of<unk>  in people with risk factors including existing cardiovascular disease, diabetes, or stroke, but having relatively low LDL cholesterol. In this trial, which lasted 5.4 years, overall mortality was reduced by 13% and cardiovascular mortality was reduced by 18%. People receiving<unk>  experienced 38% fewer nonfatal heart attacks and 25% fewer strokes. Statins in general have been proposed as beneficial in reducing the progression of Age-related Macular Degeneration (AMD). Multiple observational studies have been conducted to analyse the benefits of statin use in delaying the progression of AMD but have resulted in conflicting outcomes. Given the current available information,<unk>  should not be recommended solely for the treatment of AMD.
Simvastatin
Ezetimibe
Fluvastatin
Lovastatin
Clofibrate
Atorvastatin
Fenofibrate
Pravastatin